Cargando…

OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers

The pervasive role of microRNAs (miRNAs) in cancer pathobiology drives the introduction of new drug development approaches such as miRNA inhibition. In order to advance miRNA-therapeutics, meticulous screening strategies addressing specific tumor targets are needed. Small molecule inhibitors represe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monroig-Bosque, Paloma del C., Shah, Maitri Y., Fu, Xiao, Fuentes-Mattei, Enrique, Ling, Hui, Ivan, Cristina, Nouraee, Nazila, Huang, Beibei, Chen, Lu, Pileczki, Valentina, Redis, Roxana S., Jung, Eun-Jung, Zhang, Xinna, Lehrer, Michael, Nagvekar, Rahul, Mafra, Ana Carolina P., Monroig-Bosque, Maria del Mar, Irimie, Alexandra, Rivera, Carlos, Dan Dumitru, Calin, Berindan-Neagoe, Ioana, Nikonowicz, Edward P., Zhang, Shuxing, Calin, George A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117344/ https://www.ncbi.nlm.nih.gov/pubmed/30166612 http://dx.doi.org/10.1038/s41598-018-30989-3

Ejemplares similares

MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression
por: de Melo Maia, Beatriz, et al.
Publicado: (2016)

Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells
por: Pileczki, Valentina, et al.
Publicado: (2016)

OMCD: OncomiR Cancer Database
por: Sarver, Aaron L., et al.
Publicado: (2018)

OncomiRs: the discovery and progress of microRNAs in cancers
por: Cho, William CS
Publicado: (2007)

OncomiR-17-5p: alarm signal in cancer?
por: Bobbili, Madhusudhan Reddy, et al.
Publicado: (2017)

Down-regulation of traditional oncomiRs in plasma of breast cancer patients
por: Jurkovicova, Dana, et al.
Publicado: (2017)

A structural map of oncomiR-1 at single-nucleotide resolution
por: Chakraborty, Saikat, et al.
Publicado: (2017)

Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
por: Gilles, Maud-Emmanuelle, et al.
Publicado: (2019)

Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy
por: Wang, Yazhe, et al.
Publicado: (2023)

Linifanib
Publicado: (2012)

miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma
por: Liang, Hongwei, et al.
Publicado: (2016)

miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer
por: Li, Yan, et al.
Publicado: (2019)

Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?
por: Jeang, Kuan-Teh
Publicado: (2010)

MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
por: Banno, Kouji, et al.
Publicado: (2014)

miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4
por: Liu, Yanqing, et al.
Publicado: (2016)

OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications
por: Otmani, Khalid, et al.
Publicado: (2022)

OncomiR Addiction Is Generated by a miR-155 Feedback Loop in Theileria-Transformed Leukocytes
por: Marsolier, Justine, et al.
Publicado: (2013)

Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
por: Das, Ani V., et al.
Publicado: (2015)

Prognostic and Therapeutic Potentials of OncomiRs Modulating mTOR Pathways in Virus-Associated Hepatocellular Carcinoma
por: Nadda, Neeti, et al.
Publicado: (2021)

Author Correction: miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma
por: Liang, Hongwei, et al.
Publicado: (2021)

EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas
por: Nourmohammadi, Fatemeh, et al.
Publicado: (2022)

Cracking the case: The diagnosis and treatment of a complex high-grade endometrial carcinoma with hepatoid, endometrioid, serous features and somatically derived yolk sac tumor component in a 50 year old female
por: O'Connell, Cailin, et al.
Publicado: (2023)

BRCA1 as a tumor suppressor linked to the regulation of epigenetic states: keeping oncomiRs under control
por: Stefansson, Olafur Andri, et al.
Publicado: (2012)

miR-3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression
por: Yang, Xiu-Hua, et al.
Publicado: (2018)

C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas
por: Di Pascale, Federica, et al.
Publicado: (2018)

Effect of Combined Perftoran and Indocyanine Green-Photodynamic Therapy on HypoxamiRs and OncomiRs in Lung Cancer Cells
por: Gamal-Eldeen, Amira M., et al.
Publicado: (2022)

Environmental and Lifestyle Cancer Risk Factors: Shaping Extracellular Vesicle OncomiRs and Paving the Path to Cancer Development
por: Bollati, Valentina, et al.
Publicado: (2023)

New insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR
por: Perez‐Añorve, Isidro X., et al.
Publicado: (2019)

Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer
por: Dhar, Swati, et al.
Publicado: (2015)

Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma
por: Janiszewska, Joanna, et al.
Publicado: (2015)

The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients
por: Mavridis, K, et al.
Publicado: (2015)

miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis
por: Seashols-Williams, S. J., et al.
Publicado: (2016)

The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b
por: Ma, Qiang, et al.
Publicado: (2015)

Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis
por: Budd, William T., et al.
Publicado: (2015)

Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level
por: Wang, Dong, et al.
Publicado: (2018)

Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma
por: Liu, Chia-Hsin, et al.
Publicado: (2022)

p53 siRNA - a therapeutic tool with significant implication in the modulation of apoptosis and angiogenic pathways
por: BRAICU, OVIDIU, et al.
Publicado: (2015)

OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway
por: Lu, Ya-Ching, et al.
Publicado: (2014)

Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis
por: Barnaś, Edyta, et al.
Publicado: (2023)

A 57‐year‐old woman with falls, slurred speech, and abnormal MRI signal in the pons, middle cerebellar peduncles, and cerebellum
por: Holloman, Ashley, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_djlhvv8i2ktse868eki2eppj89